Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Informatio from Ipsen Pharmaceuticals Ltd on risk of benign and malignant neoplasia of INCRELEX 10mg/ml Solution for Injection (mecasermin)
Important Safety Information - INCRELEX (mecasermin)